PHARMA MAR, S.A. «...678910...» Página 7 de 18 desde 01/07/1988 hasta 27/09/2024 28/06/2018 14:01 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings. - Employees share and stock ownership schemes It is reported that all proposed resolutions submitted by the Board to the General Shareholders’ Meeting have been approved. Número de registro: 267302 28/06/2018 10:41 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings The Company sends press release regarding its Shareholders General Meeting Número de registro: 267280 28/06/2018 10:38 PHARMA MAR, S.A. Strategic plans, profit forecasts and presentations. - Announcements and resolutions of general shareholders meetings Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman and by the Chief Financial Officer of the Company. Número de registro: 267279 26/06/2018 18:02 PHARMA MAR, S.A. Announcements of public presentations and meetings. - Strategic agreements with third parties In relation to Significant Fact n 264978, Pharma Mar informs it has entered into a mutual early termination agreement with Chugai. Número de registro: 267170 Relacionado con 264978 del 27/04/2018 (17:49) 12/06/2018 08:34 PHARMA MAR, S.A. Strategic plans, profit forecasts and presentations New corporate presentation (English version) which will be available in the Company´s web site. Número de registro: 266657 12/06/2018 08:26 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks Protocol amendment submitted to change primary endpoint of ATLANTIS Phase III trial in small-cell lung cancer patients. Número de registro: 266656 04/06/2018 17:39 PHARMA MAR, S.A. Liquidity contracts and specialists The Company announces that has entered into a liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U. Número de registro: 266399 Relacionado con 270156 del 04/10/2018 (11:23) 01/06/2018 11:07 PHARMA MAR, S.A. Liquidity contracts and specialists The Company announces the termination of the liquidity agreement entered into on July, 10, 2017 with Mediación Bursátil, Sociedad de Valores, S.A. Número de registro: 266338 Relacionado con 254397 del 10/07/2017 (12:02) 29/05/2018 08:22 PHARMA MAR, S.A. R&D: new licenses, patents and registered trademarks After analysis of the safety data of more than 500 patients, IDMC recommends that the Phase III trial with Zepsyre® in small-cell lung cancer patients should continue without any changes Número de registro: 266184 24/05/2018 08:30 PHARMA MAR, S.A. Announcements and resolutions of general shareholders meetings The Company sends notice of call, proposed resolutions and Directors´ Compensation Policy for 2019-2021 in relation to item Seven of the Agenda of the General Shareholders´ Meeting of Pharma Mar, S.A. Número de registro: 266065 Página 7 de 18 «...678910...»